Jiangsu Hengrui Medicine Co Ltd (600276)

Shanghai
51.58
+1.97(+3.97%)
  • Volume:
    96,591,664
  • Bid/Ask:
    51.58/51.59
  • Day's Range:
    47.80 - 51.89
  • Type:Equity
  • Market:China
  • ISIN:CNE0000014W7

600276 Overview

Prev. Close
49.61
Day's Range
47.8-51.89
Revenue
28.52B
Open
49
52 wk Range
44.33-97.39
EPS
0.99
Volume
96,591,664
Market Cap
316.14B
Dividend (Yield)
0.14
(0.34%)
Average Vol. (3m)
57,286,337
P/E Ratio
49.90
Beta
0.83
1-Year Change
-34.95%
Shares Outstanding
6,372,510,894
Next Earnings Date
Oct 20, 2021
What is your sentiment on Jiangsu Hengrui Medicine Co Ltd?
or
Market is currently closed. Voting is open during market hours.

Jiangsu Hengrui Medicine Co Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuyNeutralSell
Technical IndicatorsStrong BuyStrong BuyStrong BuyNeutralStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell

Jiangsu Hengrui Medicine Co Ltd Company Profile

Jiangsu Hengrui Medicine Co Ltd Company Profile

Employees
28903
Market
China

Jiangsu Hengrui Pharmaceuticals Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.

Read More
  • I think HLB(028300: KOSDAQ) in Korean market is better, which has bigger apatinib global market except China, and it's market capital is about 1/10 of Hengrui Medicine.
    3
    • sad that the shorts still have control over the company(HLB)
      0
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.